These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8659610)

  • 1. Hypothalamic-pituitary-adrenocortical activity and response to cognitive behavior therapy in unmedicated, hospitalized depressed patients.
    Thase ME; Dubé S; Bowler K; Howland RH; Myers JE; Friedman E; Jarrett DB
    Am J Psychiatry; 1996 Jul; 153(7):886-91. PubMed ID: 8659610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dexamethasone suppression test in adolescent outpatients with major depressive disorder.
    Birmaher B; Dahl RE; Ryan ND; Rabinovich H; Ambrosini P; al-Shabbout M; Novacenko H; Nelson B; Puig-Antich J
    Am J Psychiatry; 1992 Aug; 149(8):1040-5. PubMed ID: 1636803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dexamethasone suppression test in patients with mood disorders.
    Rush AJ; Giles DE; Schlesser MA; Orsulak PJ; Parker CR; Weissenburger JE; Crowley GT; Khatami M; Vasavada N
    J Clin Psychiatry; 1996 Oct; 57(10):470-84. PubMed ID: 8909334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothalamic-pituitary-adrenocortical function in mixed and pure mania.
    Swann AC; Stokes PE; Casper R; Secunda SK; Bowden CL; Berman N; Katz MM; Robins E
    Acta Psychiatr Scand; 1992 Apr; 85(4):270-4. PubMed ID: 1595360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study.
    Stokes PE; Stoll PM; Koslow SH; Maas JW; Davis JM; Swann AC; Robins E
    Arch Gen Psychiatry; 1984 Mar; 41(3):257-67. PubMed ID: 6367690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining the boundaries of atypical depression: evidence from the HPA axis supports course of illness distinctions.
    Stewart JW; Quitkin FM; McGrath PJ; Klein DF
    J Affect Disord; 2005 Jun; 86(2-3):161-7. PubMed ID: 15935235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary free cortisol levels and dexamethasone suppression testing in organic affective disorder associated with hyperthyroidism.
    Kathol RG; Delahunt JW; Cooke R
    Am J Psychiatry; 1985 Oct; 142(10):1193-5. PubMed ID: 4037132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DST studies in psychotic depression: a meta-analysis.
    Nelson JC; Davis JM
    Am J Psychiatry; 1997 Nov; 154(11):1497-503. PubMed ID: 9356556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dexamethasone suppression test in adolescent psychiatric inpatients.
    Targum SD; Capodanno AE
    Am J Psychiatry; 1983 May; 140(5):589-91. PubMed ID: 6846588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depression.
    Bschor T; Baethge C; Adli M; Eichmann U; Ising M; Uhr M; Müller-Oerlinghausen B; Bauer M
    Depress Anxiety; 2003; 17(1):43-8. PubMed ID: 12577277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dexamethasone suppression index: enhancement of DST diagnostic utility for depression by expressing serum cortisol as a function of serum dexamethasone.
    Arana GW; Reichlin S; Workman R; Haaser R; Shader RI
    Am J Psychiatry; 1988 Jun; 145(6):707-11. PubMed ID: 3369557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendocrine aspects of primary endogenous depression. III. Cortisol secretion in relation to diagnosis and symptom patterns.
    Rubin RT; Poland RE; Lesser IM; Martin DJ; Blodgett AL; Winston RA
    Psychol Med; 1987 Aug; 17(3):609-19. PubMed ID: 3628622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dexamethasone suppression test: an overview of its current status in psychiatry. The APA Task Force on Laboratory Tests in Psychiatry.
    Am J Psychiatry; 1987 Oct; 144(10):1253-62. PubMed ID: 3310667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroendocrine aspects of primary endogenous depression. I. Cortisol secretory dynamics in patients and matched controls.
    Rubin RT; Poland RE; Lesser IM; Winston RA; Blodgett AL
    Arch Gen Psychiatry; 1987 Apr; 44(4):328-36. PubMed ID: 3566455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects.
    Heuser IJ; Schweiger U; Gotthardt U; Schmider J; Lammers CH; Dettling M; Yassouridis A; Holsboer F
    Am J Psychiatry; 1996 Jan; 153(1):93-9. PubMed ID: 8540599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do depressed men and women respond similarly to cognitive behavior therapy?
    Thase ME; Reynolds CF; Frank E; Simons AD; McGeary J; Fasiczka AL; Garamoni GG; Jennings JR; Kupfer DJ
    Am J Psychiatry; 1994 Apr; 151(4):500-5. PubMed ID: 8147447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of depressive history on biological parameters in major depression].
    Van Wijnendaele R; Hubain P; Dramaix M; Mendlewicz J; Linkowski P
    Encephale; 2002; 28(1):51-8. PubMed ID: 11963343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenocortical function and plasma norepinephrine in normal human subjects.
    Sotsky SM; Lake CR; Goodwin FK
    Biol Psychiatry; 1981 Jul; 16(7):643-51. PubMed ID: 7272380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dexamethasone suppression test and pituitary-adrenocortical function.
    Brown WA; Keitner G; Qualls CB; Haier R
    Arch Gen Psychiatry; 1985 Feb; 42(2):121-3. PubMed ID: 3977539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depression and the dexamethasone suppression test (DST) in patients with non-specific somatic complaints. Atypical depression and DST.
    Syvälahti E; Hyyppä MT; Salminen JK
    Ann Clin Res; 1985; 17(4):148-51. PubMed ID: 4073803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.